Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

PCN Insights, News, Videos, and More

goldberg
Podcasts
12/29/2021
Dr Joseph Goldberg provides information on how lithium use for bipolar disorder can cause tardive dyskinesia and how to correctly identify and address this problem.
Dr Joseph Goldberg provides information on how lithium use for bipolar disorder can cause tardive dyskinesia and how to correctly identify and address this problem.
Dr Joseph Goldberg provides...
12/29/2021
Psych Congress Network
News
12/24/2021
Jolynn Tumolo
ADHD is a valid mental health diagnosis with the potential to improve the lives of people lives with ADHD and its complications worldwide.
ADHD is a valid mental health diagnosis with the potential to improve the lives of people lives with ADHD and its complications worldwide.
ADHD is a valid mental health...
12/24/2021
Psych Congress Network
News
12/23/2021
Meagan Thistle
Psych Congress Europe will be held in Barcelona, Spain, February 23-25 and promises to connect the global mental healthcare community with updated approaches in practical psychopharmacology.
Psych Congress Europe will be held in Barcelona, Spain, February 23-25 and promises to connect the global mental healthcare community with updated approaches in practical psychopharmacology.
Psych Congress Europe will be...
12/23/2021
Psych Congress Network
Dr Goldberg
Podcasts
12/23/2021
Dr Golberg answers the question, what are your “thoughts on [bipolar disorder] treatment options for sexually active women of child-bearing age who are rapid cycling?”
Dr Golberg answers the question, what are your “thoughts on [bipolar disorder] treatment options for sexually active women of child-bearing age who are rapid cycling?”
Dr Golberg answers the question,...
12/23/2021
Psych Congress Network
Craig Chepke
Videos
12/22/2021
Psych Congress Steering Committee Member Craig Chepke, MD, FAPA, shares why he is looking forward to Psych Congress' Expansion into Europe in 2022.
Psych Congress Steering Committee Member Craig Chepke, MD, FAPA, shares why he is looking forward to Psych Congress' Expansion into Europe in 2022.
Psych Congress Steering...
12/22/2021
Psych Congress Network
News
12/22/2021
Meagan Thistle
Patients taking zuranolone saw rapid improvements in depressive and elevated anxiety symptoms, according to data presented by Sage Therapeutics and Biogen.
Patients taking zuranolone saw rapid improvements in depressive and elevated anxiety symptoms, according to data presented by Sage Therapeutics and Biogen.
Patients taking zuranolone saw...
12/22/2021
Psych Congress Network
Goldberg
Podcasts
12/21/2021
Dr Joseph F Golberg discusses L-methylfolate for the treatment of bipolar disorder, as well as how sleep comorbidities and weight gain phobia impact treatment options.
Dr Joseph F Golberg discusses L-methylfolate for the treatment of bipolar disorder, as well as how sleep comorbidities and weight gain phobia impact treatment options.
Dr Joseph F Golberg discusses...
12/21/2021
Psych Congress Network
News
12/21/2021
Jolynn Tumolo
According to new research, behavior improvements in children with ADHD following a few-foods diet were reflected in their brain activity
According to new research, behavior improvements in children with ADHD following a few-foods diet were reflected in their brain activity
According to new research,...
12/21/2021
Psych Congress Network
Lindsay Galvin Rauch
Videos
12/20/2021
Sibling of 6 brothers diagnosed with schizophrenia, says clinicians, families, and law enforcement could benefit from education about the disorder, specifically the comorbid condition of anosognosia.
Sibling of 6 brothers diagnosed with schizophrenia, says clinicians, families, and law enforcement could benefit from education about the disorder, specifically the comorbid condition of anosognosia.
Sibling of 6 brothers diagnosed...
12/20/2021
Psych Congress Network
News
12/20/2021
Erin McGuinness
The US Food and Drug Administration (FDA) has approved Intra-Cellular Therapies, Inc’s CAPLYTA® (lumaterperone) for the treatment of adult bipolar depression.
The US Food and Drug Administration (FDA) has approved Intra-Cellular Therapies, Inc’s CAPLYTA® (lumaterperone) for the treatment of adult bipolar depression.
The US Food and Drug...
12/20/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement